tiprankstipranks
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market

Aclaris Therapeutics (ACRS) Income Statement

Compare
727 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q3 2024), Aclaris Therapeutics's total revenue was $4.35M, a decrease of -53.18% from the same quarter last year. In Q3, Aclaris Therapeutics's net income was $-7.59M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 31.25M$ 29.75M$ 6.76M$ 6.48M$ 4.23M
Gross Profit
$ 13.17M$ 17.79M$ 2.05M$ 1.35M$ 172.00K
Operating Expenses
$ 110.53M$ 102.95M$ 67.43M$ 52.26M$ 92.73M
Depreciation and Amortization
$ 863.00K$ 797.00K$ 923.00K$ 1.32M$ 1.59M
EBITDA
$ -117.56M$ -84.36M$ -65.06M$ -48.20M$ -90.84M
Operating Income
$ -97.36M$ -85.15M$ -65.38M$ -50.91M$ -111.06M
Other Income/Expenses
$ 8.51M$ 2.95M$ -1.14M$ -424.00K$ -2.48M
Pretax Income
$ -88.85M$ -86.91M$ -90.86M$ -51.34M$ -113.54M
Net Income
$ -88.48M$ -88.66M$ -114.28M$ -51.15M$ -142.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.27$ -1.36$ -2.01$ -1.20$ -3.46
Diluted EPS
$ -1.27$ -1.36$ -2.01$ -1.20$ -3.46
Weighted Average Shares Outstanding
69.81M 65.21M 56.73M 42.54M 41.32M
Weighted Average Shares Outstanding (Diluted)
69.81M 65.21M 56.73M 42.54M 41.32M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis